DAX24.841 -0,1%Est505.969 -0,7%MSCI World4.343 -0,1%Top 10 Crypto8,6500 +2,7%Nas22.571 -0,1%Bitcoin57.051 +2,3%Euro1,1862 -0,1%Öl67,47 -0,1%Gold5.000 +1,6%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Siemens 723610 Deutsche Telekom 555750 Siemens Energy ENER6Y Rheinmetall 703000 SAP 716460 Amazon 906866 NVIDIA 918422 Mercedes-Benz Group (ex Daimler) 710000 Lufthansa 823212 BASF BASF11 Microsoft 870747 Heidelberg Materials 604700 Deutsche Bank 514000 DroneShield A2DMAA Allianz 840400
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Nach US-Inflationsdaten: DAX stabil -- Wall Street im Minus -- Amazon im Bärenmarkt -- Delivery Hero, pbb, Siemens, RWE, Rivian, Applied Materials, Adyen, Apple, Arista im Fokus
Top News
Procore Technologies: Jefferies sieht nach der Präsentation des Quartalsberichts 81 % Kurspotenzial! Procore Technologies: Jefferies sieht nach der Präsentation des Quartalsberichts 81 % Kurspotenzial!
NASDAQ Composite Index-Papier Starbucks-Aktie: So viel Verlust wäre bei einem Investment in Starbucks von vor 3 Jahren angefallen NASDAQ Composite Index-Papier Starbucks-Aktie: So viel Verlust wäre bei einem Investment in Starbucks von vor 3 Jahren angefallen
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

CryoLife Aktie

Kaufen
Verkaufen
CryoLife Aktien-Sparplan
33,90 EUR -0,40 EUR -1,17 %
STU
38,46 USD -2,16 USD -5,32 %
BTT
CryoLife jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.1,60 Mrd. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN900006

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS2289031005

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolAORT

CryoLife Aktien News

DatumMeistgelesen
PR NewswireArtivion Reports Third Quarter 2025 Financial Results
PR NewswireArtivion Announces Treatment of First Patient with Arcevo LSA in ARTIZEN Pivotal Trial
PR NewswireArtivion to Participate in the Stifel 2025 Healthcare Conference
Wer­bungCryoLife-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireArtivion Announces Release Date and Teleconference Call Details for Third Quarter 2025 Financial Results
PR NewswireArtivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE and AMDS PROTECT Trials at the 39th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting
PR NewswireArtivion to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
PR NewswireArtivion Reports Second Quarter 2025 Financial Results
PR NewswireArtivion to Participate in Upcoming Investor Conferences
PR NewswireArtivion Announces Release Date and Teleconference Call Details for Second Quarter 2025 Financial Results
PR NewswireArtivion to Participate in Upcoming Investor Conferences
PR NewswireArtivion Reports First Quarter 2025 Financial Results
PR NewswireArtivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting
PR NewswireArtivion Announces Release Date and Teleconference Call Details for First Quarter 2025 Financial Results
PR NewswireArtivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
PR NewswireArtivion Reports Fourth Quarter and Full Year 2024 Financial Results
PR NewswireArtivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results
PR NewswireArtivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting
PR NewswireArtivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis
PR NewswireArtivion Reports Third Quarter 2024 Financial Results
PR NewswireArtivion to Participate in Upcoming Investor Conferences
PR NewswireArtivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results
PR NewswireArtivion Announces Presentation of Late-Breaking Clinical Data at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting
PR NewswireArtivion Reports Second Quarter 2024 Financial Results
PR NewswireArtivion to Participate in Upcoming Investor Conferences
PR NewswireArtivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results
PR NewswireArtivion Amends Agreements with Endospan
PR NewswireArtivion Reports First Quarter 2024 Financial Results
PR NewswireArtivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting
PR NewswireArtivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
PR NewswireArtivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference
PR NewswireArtivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
PR NewswireArtivion Reports Fourth Quarter and Full Year 2023 Financial Results
PR NewswireArtivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results
PR NewswireArtivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting
PR NewswireArtivion Obtains $350 Million in Senior Secured Credit Facilities
PR NewswireArtivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer; Announces Retirement of D. Ashley Lee, Chief Financial Officer
PR NewswireArtivion Announces Completion of Enrollment in PERSEVERE Trial
PR NewswireArtivion to Participate in Upcoming Investor Conferences
PR NewswireArtivion Reports Third Quarter 2023 Financial Results
PR NewswireArtivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results

CryoLife News

CryoLife News: auf dieser Seite finden Sie alle CryoLife News und Nachrichten zur CryoLife Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch CryoLife News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um CryoLife News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.